MSFT vs TSEM

Microsoft exhibits strong fundamental health with a Piotroski F-Score of 7/9, indicating robust financial stability. While the stock is currently experiencing a severe technical downtrend (0/100) and significant 6-month price depreciation (-28.6%), the current price of $374.33 sits well below the growth-based intrinsic value of $471.41 and the analyst target of $587.31. Exceptional earnings growth (59.8% YoY) and high operating margins (47.09%) suggest that the current price correction presents a value opportunity despite bearish insider sentiment.

TSEM exhibits a stable financial health profile with a Piotroski F-Score of 4/9 and an exceptionally strong balance sheet characterized by negligible debt. However, the stock is severely overvalued, trading at $224.49—nearly four times its growth-based intrinsic value of $56.93 and nearly seven times its Graham Number of $33.56. While earnings growth is robust, the P/E of 116.32 and PEG of 5.44 indicate that the current price has far outpaced fundamental growth. The combination of a bearish technical trend (10/100) and a current price significantly above the analyst target of $168.57 suggests a high risk of a correction.